SCHEMBL25822697

SCHEMBL25822697

c1cn2c(n1)c(Nc1ccc(C3CCOCC3)cc1)nc1ccc(-c3cn[nH]c3)cc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 5/20 0.53
MAPKAPK5 Q8IW41 2/20 0.49
MAP4K1 Q92918 1/20 0.46
AURKB Q96GD4 2/20 0.44
AURKA O14965 1/20 0.44
PTK6 Q13882 4/20 0.41
LCK P06239 1/20 0.41
ROCK2 O75116 6/20 0.40
ROCK1 Q13464 1/20 0.38
JAK2 O60674 1/20 0.38
NTRK1 P04629 1/20 0.38
ROS1 P08922 1/20 0.38
CSNK2A2 P19784 1/20 0.38
FLT3 P36888 1/20 0.38
CSNK2B P67870 1/20 0.38
CSNK2A1 P68400 1/20 0.38
BTK Q06187 1/20 0.38
CSNK2A3 Q8NEV1 1/20 0.38
JUN P05412 1/20 0.37
MAPK8 P45983 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25822675 0.86 MAPKAPK5 (0.67) SYKMAPKAPK5AURKBAURKAPTK6
SCHEMBL25822785 0.82 MAP4K1 (0.43) SYKMAPKAPK5MAP4K1AURKBAURKA
SCHEMBL25822757 0.82 SYK (0.47) SYKMAPKAPK5LCKMAPK8
SCHEMBL25822696 0.82 MAPKAPK5 (0.56) SYKMAPKAPK5AURKBAURKAPTK6
SCHEMBL25822684 0.81 SYK (0.57) SYKMAPKAPK5JAK2
SCHEMBL25822683 0.80 MAPKAPK5 (0.54) SYKMAPKAPK5MAP4K1AURKBAURKA
SCHEMBL25822681 0.79 MAPKAPK5 (0.67) SYKMAPKAPK5AURKBAURKAPTK6
SCHEMBL25822687 0.78 SYK (0.54) SYKMAPKAPK5AURKBAURKAPTK6
SCHEMBL25822692 0.78 MAPKAPK5 (0.51) SYKMAPKAPK5AURKBAURKAPTK6
SCHEMBL25822689 0.78 MAPKAPK5 (0.51) SYKMAPKAPK5MAP4K1PTK6ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219960-A1 1H-PYRAZOLE DERIVATIVE AND APPLICATION THEREOF AS DUAL TARGET INHIBITOR OF SYK AND VEGFR2 OCUMENSION THERAPEUTICS (SUZHOU) CO., LTD. (CN) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219960-A1 1H-PYRAZOLE DERIVATIVE AND APPLICATION THEREOF AS DUAL TARGET INHIBITOR OF SYK AND VEGFR2 SYK, KDR, FLT1 SYK 1/4885MAPKAPK5 216/4885MAP4K1 445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.